SARS-CoV-2 Specific Antibody Responses and Impact for COVID-19 Disease in Ethiopia

Abroad (travel likely)Recruiting

Conditions

SARS CoV 2 Infection · COVID-19 Breakthrough · COVID-19 Recurrent

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Department of Microbiology Immunology and Parasitology, Addis Ababa, Ethiopia
Contact: Study coordinator (Solomon Ali, PhD) · solomon.ali@sphmmc.edu.et · +251911488680
Jimma University, Jimma, Ethiopia
Contact: Study coordinator (Esayas K Gudina, MD, PhD) · Esayas.kebede@ju.edu.et · +251917550576

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Safety and Immunogenicity Trial of OCU500, ChAd36 Vector Encoding SARS-CoV-2 Spike Vaccine Via Intranasal and Inhalational Routes in Previously Vaccinated Adults

COVID-19

Abroad (travel likely)RecruitingPHASE1

Decatur, United States · Baltimore, United States

The Impact of COVID-19 on Maternal and Neonatal Outcomes

COVID-19 · Pregnancy; Infection

Abroad (travel likely)Recruiting

Baltimore, United States

International Survey of Acute Coronavirus Syndromes-COVID-19

COVID-19

Abroad (travel likely)Recruiting

Bologna, Italy · Barcelona, Spain

Dime La VerDAD: Verify, Debunk, and Disseminate

Influenza · COVID-19 · Communication Research

Abroad (travel likely)Recruiting

Chicago, United States · Chicago, United States